Nuwellis closes acquisition of Rendiatech, automated kidney monitoring tech

Nuwellis, Inc.

Closed acquisition of Rendiatech, Inc., an Israeli developer of automated kidney function monitoring technology.
Acquisition previously announced; no financial terms disclosed in this filing.
Technology intended to support clinical decision-making in critically ill patients.
Nuwellis expands product portfolio with monitoring capability.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.